Risk Prediction Models: A Framework for Assessment

被引:8
作者
Dent, T. H. S. [1 ]
Wright, C. F. [1 ]
Stephan, B. C. M. [2 ]
Brayne, C. [2 ]
Janssens, A. C. J. W. [3 ]
机构
[1] Univ Cambridge, PHG Fdn, Cambridge CB1 8RN, England
[2] Univ Cambridge, Inst Publ Hlth, Cambridge, England
[3] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands
基金
英国医学研究理事会;
关键词
Assessment; Evaluation; Genetic; Risk prediction; PROGNOSTIC MODEL; BREAST;
D O I
10.1159/000334436
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Medical risk prediction models estimate the likelihood of future health-related events. Many make use of information derived from analysis of the genome. Models predict health outcomes such as cardiovascular disease, stroke and cancer, and for some conditions several models exist. Although risk models can help decision-making in clinical medicine and public health, they can also be harmful, for example, by misdirecting clinical effort away from those who are most likely to benefit towards people with less need, thus exacerbating health inequalities. Discussion: Risk prediction models need careful assessment before implementation, but the current approach to their development, evaluation and implementation is inappropriate. As a result, some models are pressed into use before it is clear whether they are suitable, while in other cases there is confusion about which model to use. This paper proposes an approach to the appraisal of risk-scoring models, based on a conference of UK experts. Summary: By specifying what needs to be known before a model can be judged suitable for translation from research into practice, we can ensure that useful models are taken up promptly, that less well-proven ones undergo further evaluation and that resources are not wasted on ineffective ones. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:98 / 105
页数:8
相关论文
共 17 条
[1]   Prognosis and prognostic research: validating a prognostic model [J].
Altman, Douglas G. ;
Vergouwe, Yvonne ;
Royston, Patrick ;
Moons, Karel G. M. .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 :1432-1435
[2]  
[Anonymous], 2009, BMJ
[3]   The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions [J].
Antoniou, A. C. ;
Cunningham, A. P. ;
Peto, J. ;
Evans, D. G. ;
Lalloo, F. ;
Narod, S. A. ;
Risch, H. A. ;
Eyfjord, J. E. ;
Hopper, J. L. ;
Southey, M. C. ;
Olsson, H. ;
Johannsson, O. ;
Borg, A. ;
Passini, B. ;
Radice, P. ;
Manoukian, S. ;
Eccles, D. M. ;
Tang, N. ;
Olah, E. ;
Anton-Culver, H. ;
Warner, E. ;
Lubinski, J. ;
Gronwald, J. ;
Gorski, B. ;
Tryggvadottir, L. ;
Syrjakoski, K. ;
Kallioniemi, O-P ;
Eerola, H. ;
Nevanlinna, H. ;
Pharoah, P. D. P. ;
Easton, D. F. .
BRITISH JOURNAL OF CANCER, 2008, 98 (08) :1457-1466
[4]   Predicting the risk of coronary heart disease. II: The role of novel molecular biomarkers and genetics in estimating risk, and the future of risk prediction [J].
Dent, T. H. S. .
ATHEROSCLEROSIS, 2010, 213 (02) :352-362
[5]   Predicting the risk of coronary heart disease I. The use of conventional risk markers [J].
Dent, T. H. S. .
ATHEROSCLEROSIS, 2010, 213 (02) :345-351
[6]   A practical guide to interpretation and clinical application of personal genomic screening [J].
Edelman, Emily ;
Eng, Charis .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 :1136-1140
[7]   PROJECTING INDIVIDUALIZED PROBABILITIES OF DEVELOPING BREAST-CANCER FOR WHITE FEMALES WHO ARE BEING EXAMINED ANNUALLY [J].
GAIL, MH ;
BRINTON, LA ;
BYAR, DP ;
CORLE, DK ;
GREEN, SB ;
SCHAIRER, C ;
MULVIHILL, JJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (24) :1879-1886
[8]  
Haddow J.E., 2004, HUMAN GENOME EPIDEMI, P217
[9]   Outcome prediction in critical care: the ICNARC model [J].
Harrison, David A. ;
Rowan, Kathryn M. .
CURRENT OPINION IN CRITICAL CARE, 2008, 14 (05) :506-512
[10]  
Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278